FOXOOTCServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as FOXOW
FOXO TECHNOLOGIES INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.10−0.01 (-9.09%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
FOXO TECHNOLOGIES INC. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Cares [Member] | $4.47M | $4.80M | $4.21M | $3.51M | $5.21M | $3.16M | $2.81M | $1.19M | $20.19K | – | – | – | 94.8% | -14.2% |
| Life Science Services [Member] | $238.46K | $361.25K | $220.87K | $31.63K | – | – | – | – | – | – | – | – | 5.1% | – |
| Labs [Member] | $6.20K | $4.39K | – | $8.24K | $7.82K | $8.49K | $9.42K | $8.75K | $7.29K | – | – | – | 0.1% | -20.6% |
| Labs and Life [Member] | – | – | – | – | – | $8.49K | $9.64K | $8.00K | $8.00K | $7.18K | $110.29K | $10.00K | – | – |
| Corporate Segment and Other Operating Segment [Member] | – | $3.85K | – | – | – | – | – | – | – | – | – | – | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Foxo Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.